In this episode, Geeta Vemuri talks to us about her journey into healthcare focused venture capital and applying science to business. She also addresses how the current environment has prompted her team to look into opportunities that are opening up in the form supply chain disruptions and her philosophy that there is no right time to start a company.Geeta is a founder and managing partner at Agent Capital, one of only 4 majority women owned U.S. based Bio Pharma Venture Capital funds, investing in companies that look to treat oncology, immunology, rare diseases, and neurology. Geeta came to the U.S. in 1992 following an invitation to do her post-doc from a national academy of science scientist, but upon arriving, she realized her passion for taking science from the lab and translating it into businesses. She previously held the role of Vice President at Baxalta Ventures along with Vice President of Baxter Ventures. Geeta earned her Ph.D in biochemistry from the Indian Institute of Science and her MBA from Wharton.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related